Uploaded on

TexRAD is a software application that analyses the textures in existing radiological scans to assist the clinician in assessing the prognosis of patients with cancer

TexRAD is a software application that analyses the textures in existing radiological scans to assist the clinician in assessing the prognosis of patients with cancer

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
610
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Renal Demo 1 Renal Metastases Demo TexRAD: Potential predictive imaging biomarker of response to treatment in metastatic renal cancer TexRAD PRE-TREATMENT Case Study | Demo | Evidence Screenshot of the Renal TexRAD highlighting ‘Right lobe liver’ metastases (pre-treatment) on the conventional CT image (top-left), followed by the derived texture maps superimposed on the conventional CT image – fine (red), medium (green) and coarse (blue) texture 5 6 6 7 8 1 2 3 4
  • 2. Renal Demo 2 Renal Metastases Demo TexRAD: Potential predictive imaging biomarker of response to treatment in metastatic renal cancer TexRAD POST-TREATMENT Case Study | Demo | Evidence Screenshot of the Renal TexRAD highlighting ‘Right lobe liver’ metastases (post-treatment) on the conventional CT image (top-left), followed by the derived texture maps superimposed on the conventional CT image – fine (red), medium (green) and coarse (blue) texture 5 6 6 7 8 1 2 3 4
  • 3. Renal Evidence 1 Renal Early Evidence Clinical Evidence – Recent findings a ccepted in ECR 2010 [1] Case Study | Demo | Evidence CT Texture significantly predicts patients with poor prognosis (treatment response) 5 6 6 7 8 1 2 3 4 p < 0.005
  • 4. Renal Evidence 2 Renal Early Evidence Clinical Evidence – Recent findings a ccepted in ECR 2010 [1] Case Study | Demo | Evidence Existing anatomical imaging response criteria (RECIST) did not significantly predict patients with poor prognosis 5 6 6 7 8 1 2 3 4
  • 5. References - Renal
    • RENAL
    • 1 Ganeshan B, Rajpopat M, Vinayan A, Nathan P, Goh V, Miles KA. CT texture and enhancement: Potential predictive imaging biomarkers of response to treatment in metastatic renal cancer. Accepted as a paper presentation in European Society of Radiology 2010, Vienna, Austria.
    References - Renal Cancer Colorectal | Lung | Breast | Prostate | Renal | Lung | Brain | DTA